JPH0331172B2 - - Google Patents
Info
- Publication number
- JPH0331172B2 JPH0331172B2 JP58075932A JP7593283A JPH0331172B2 JP H0331172 B2 JPH0331172 B2 JP H0331172B2 JP 58075932 A JP58075932 A JP 58075932A JP 7593283 A JP7593283 A JP 7593283A JP H0331172 B2 JPH0331172 B2 JP H0331172B2
- Authority
- JP
- Japan
- Prior art keywords
- aloe
- parts
- weight
- treatment member
- hydrophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001116389 Aloe Species 0.000 claims description 30
- 235000011399 aloe vera Nutrition 0.000 claims description 28
- 238000011282 treatment Methods 0.000 claims description 14
- 239000000017 hydrogel Substances 0.000 claims description 12
- 229920001577 copolymer Polymers 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 229940069521 aloe extract Drugs 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 5
- 229920002126 Acrylic acid copolymer Polymers 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 229920001477 hydrophilic polymer Polymers 0.000 claims 1
- 238000000465 moulding Methods 0.000 claims 1
- 229920002647 polyamide Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 description 11
- 238000001816 cooling Methods 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- OUPZKGBUJRBPGC-UHFFFAOYSA-N 1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound O=C1N(CC2OC2)C(=O)N(CC2OC2)C(=O)N1CC1CO1 OUPZKGBUJRBPGC-UHFFFAOYSA-N 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002964 rayon Substances 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- -1 curdline Chemical compound 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 244000101643 Aloe ferox Species 0.000 description 1
- 235000015858 Aloe ferox Nutrition 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000015877 Duodenal disease Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000554740 Rusa unicolor Species 0.000 description 1
- 241000922366 Socotra Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004535 effect on gastrointestinal diseases Effects 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001228 polyisocyanate Polymers 0.000 description 1
- 239000005056 polyisocyanate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明はシート状外用治療部材に関する。更に
詳しくは、本発明はアロエまたはアロエエキスを
含有するシート状外用治療部材に関する。
アロエは数千年前から薬草として使用され、明
治19年の日本薬局方にも蘆薈として記載され、古
くから民間薬として使用されている。
アロエの効能は下記のようなものである:
内用としては、胃腸病に対する健胃作用、胃カイ
ヨウ、十二指腸カイヨウに対する抗カイヨウ剤、
便秘に対する下剤、高血圧に対する合併症の防
止、低血圧に対する血液の循環向上、かぜに対す
るウイルスの不活化、ゼンソクに対する体質改
善、糖尿病に対する新陳代謝の活性化、肝蔵病に
対する解毒作用、乗り物酔いに対する鎮経作用、
二日酔いに対する解毒作用、など外用としては、
やけど、すり傷、切り傷に対する殺菌作用と組織
回復作用、虫さされに対する殺菌作用と毒素中和
作用、水虫に対する殺菌作用、うおのめに対する
角質軟化作用、虫歯;歯槽膿漏に対する消炎作用
口内炎に対する殺菌作用、打ち身・肩こりに対す
る消炎作用、痔に対する消炎鎮痛止血作用などが
ある。
以上のようにアロエは種々の薬効を有し、使用
に際しては、目的に応じて、生のアロエ、ジユー
ス、液汁、軟膏、錠剤等を服用又は塗布して使用
する。
ところで、アロエの外用用途で最も効果が期待
され、また効果の大きいやけど、切り傷、すり傷
の治療用として使用する場合、初期治療は早けれ
ば早い方がよい。特にやけどに対する治療の場合
は緊急を用する、したがつて市販の軟膏剤を常備
し使用することな好ましい。
また、やけど治療において重要なことは、でき
るだけ速やかに治療することはもちろんである
が、患部の冷却が必要であり、この初期冷却の度
合によつて回復の速さが決定する。その点におい
て軟膏剤は初期冷却作用が得られない欠点があ
る。また、家庭で栽培しているアロエを熱湯にく
ぐらせ殺菌した後に外皮を取り除いて葉の中のゼ
リー状の部分を患部を広く並べて貼り付ける治療
はアロエ中に含まれている多量の水分による冷却
効果が期待できると同時にアロエの薬効成分を直
接患部に作用させうるという利点があり、よく知
られた使用方法では有るが、操作がめんどうなた
めに時間がかかる欠点が有つた。
本発明の目的は、アロエの薬効を損なわず初期
冷却効果の大きいアロエ製剤を得ることにあり、
その要旨は親水性含水ゲル基剤にアロエまたはア
ロエエキスを配合し、シート状に成形してなる外
用治療部材である。
本発明に関して、親水性含水ゲル基剤として
は、通常、従来から一般的に使用されているもの
が用いられる。それは合成、天然のいずれでもよ
く、従来から親水性ゲル基剤用として用いられて
いるものはいずれも使用可能である。その代表例
としては、たとえばアルギン酸ナトリウム、アラ
ビアゴム、デキストリン、プルラン、アミロー
ス、ゼラチン、カードライン、メチルセルロー
ス、エチルセルロース、ヒドロキシエチルセルロ
ース、ヒドロキシプロピルセルロース、カルボキ
シメチルセルロースなどの糖類およびその誘導
体、ポリアクリル酸およびその塩(たとえば、ナ
トリウム塩、アンモニウム塩、アルカノールアミ
ン塩など)、アクリル酸共重合体およびその塩
(たとえば、アクリル酸・アクリル酸エチル共重
合体、アクリル酸・アクリル酸エチル共重合体の
カリウム塩など)、アクリル酸アルキルエステル
重合体(たとえば、ポリアクリル酸エチル、ポリ
アクリル酸ヒドロキシエチル、ポリアクリル酸エ
トキシエチル)、無水マレイン酸共重合体(たと
えば、メチルビニルエーテル・無水マレイン酸共
重合体、イソブチレン・無水マレイン酸共重合体
など)およびその塩(たとえば、ナトリウム塩、
アンモニウム塩など)、ポリビニルアルコールお
よびその誘導体(たとえば、部分ケン化ポリビニ
ルアルコール、カルボキシル化ポリビニルアルコ
ールなど)、アクリルアミド重合体およびその共
重合体(たとえば、アクリルアミド・アクリル酸
共重合体、アクリルアミド・アクリルニトリル・
アクリル酸共重合体、アクリルアミド・アクリル
ニトリル・アクリル酸エステル共重合体など)、
ポリビニルピロリドンなどがあげられる。かかる
高分子物質は架橋剤(たとえば、ポリイソシアネ
ート、ポリエポキシド、過酸化ベンゾイルなど)
を用いて架橋されたものであつてもよい。
親水性含水ゲル基剤における当該高分子物質の
配合量は、当該基剤の強度および冷却能の設定に
よつて異なるが、通常3〜30重量%程度である。
3重量%以下では、たとえば架橋体の状態で用い
ても含水ゲル強度が不十分であり、30重量%以上
では製造時の粘度が高すぎて作業性が悪く、高分
子物質の溶解性の点から配合可能な水分量が少な
くなり冷却能が悪くなる傾向がある。
また、基剤中には粘着付与や製造時の溶解性を
高める目的でエチレングリコール、ジエチレング
リコール、ポリエチレングリコール、プロピレン
グリコール、ポリプロピレングリコール、グリセ
リンなどの多価アルコールを併用することが好ま
しく、その使用量は、通常5〜80重量%である。
5重量%以下では添加したことによる顕著な効果
が得られず、80重量%以上では、含水ゲル強度と
冷却能が劣る。
親水性含水ゲル基剤中の水分量は10重量%以上
であれば冷却効果は期待できるが、20重量%以下
では冷却効果の消失が速く、95重量%以上では、
含水ゲル強度が不十分なために、形状や大きさに
よつては使いずらい。したがつて、好ましい含水
量は、使用される高分子物質によつても若干異な
るが、25〜70重量%、さらに好ましくは30〜60重
量%である。
薬効成分としてはアロエまたはアロエエキスが
配合されるが、目的に応じて、既知の殺菌剤、抗
炎症剤、防腐剤、充填剤、第1級アルコール等を
添加してもよい。
アロエとしては、局方記載のもの(ケープアロ
エ、ソコトラ・アロエ、キユラソウ・アロエ)を
用いることが好ましいが、もちろん他のアロエ
属、たとえばナタルアロエ、サンバーアロエ、ジ
ヤフアラバツドアロエなどを用いてもよい。アロ
エは、その粉末、アロエ液汁、アロエエキスで添
加してもよい。アロエエキスとしては、たとえば
水、エタノール等のアルコール、水−アルコール
混合溶媒などによつて抽出して製したものが使用
される。
アロエまたはアロエエキスの配合量は、アロエ
またはアロエ末として2%以上、上記のエキスと
して0.8%以上であれば効果は期待できるが、エ
キス含量として1〜15%が好適である。
本発明の治療部材は親水性含水ゲル基剤中にア
ロエ類を均一に分散又は溶解させ、これを担持体
上に延展することによつて製造される。
担持体としては布、プラスチツク等従来既知の
ものを用いればよい。
以下に実施例及び実験例を示して本発明をより
具体的に説明するが、本発明はこれらに限定され
るものではない。
なお、以下の記載において「部」とあるは「重
量部」を意味する。
実施例 1
平均重合度20000のポリアクリル酸ソーダ6部
及びグリセリン15部を水80部に溶解する。一方ト
リグリシジルイソシアヌレート0.3部を水10部に
溶解する。次にポリアクリル酸ソーダとグリセリ
ンの水溶液を撹拌しながらトリグリシジルイソシ
アヌレート水溶液を添加し、約70℃で1時間加温
後冷却し、アロエの生薬をしぼつた液汁50部を添
加混合する。この混合物をレーヨン不織布に厚み
が1.0mmとなるように塗布し、本発明の治療部材
を得る。
実施例 2
アクリル酸90部、アクリル酸ブチル10部、ポリ
オキシプロピル化ソルビトール50部、過硫酸アン
モニウム2部を水350部に溶解し、不活性ガス気
流中で60℃で8時間重合した。得られた粘稠液
100部にポリオキシプロピル化ソルビトール60部、
20%水酸化カリウム水溶液30部、10%トリグリシ
ジルイソシアヌレート水溶液10部を加え均一に混
合した後、局方アロエの水性エキス40部した液を
添加混合し、厚さ100μのレーヨン不織布に厚さ
約1mmとなるように展延しシート状治療部材を得
る。
実施例 3
無水マレイン酸・メチルビニルエーテル共重合
体(無水マレイン酸含有量50重量%)20%水溶液
100部に、ジエチレングリコール15部、トリエタ
ノールアミン1部を加えて混合し、均一に混合さ
れた後に10%グリセリンジグリシジルエーテル水
溶液20部と局方アロエ末50部を添加しレーヨン不
織布に厚みが1.0mmとなるように塗布し、常温で
架橋して本発明の治療部材を得る。
実験例 1
実施例1〜3で得た製剤を第1表に示す火傷に
適用し、その効果の判定を行い、その結果を第1
表に示した。
以上の結果から明らかなように、本発明治療部
材は市販のアロエ軟膏に比し良好な治療効果を得
た。
The present invention relates to a sheet-shaped external treatment member. More specifically, the present invention relates to a sheet-shaped external treatment member containing aloe or aloe extract. Aloe has been used as a medicinal herb for thousands of years, and was listed as Ashika in the Japanese Pharmacopoeia in 1899, and has been used as a folk medicine since ancient times. The effects of aloe are as follows: For internal use, it has a stomachic effect on gastrointestinal diseases, an anti-inflammatory agent for gastrointestinal diseases, and duodenal diseases.
Laxative for constipation, prevention of complications for high blood pressure, improving blood circulation for low blood pressure, inactivating viruses for colds, improving constitution for colds, activating metabolism for diabetes, detoxifying effect for liver disease, calming for motion sickness. action,
For external use, such as detoxification for hangovers,
Sterilizing effect and tissue recovery effect on burns, abrasions, and cuts, sterilizing effect and toxin neutralizing effect on insect bites, sterilizing effect on athlete's foot, keratin softening effect on corns, anti-inflammatory effect on tooth decay and pyorrhea, sterilizing effect on stomatitis, It has an anti-inflammatory effect on bruises and stiff shoulders, and an anti-inflammatory analgesic and hemostatic effect on hemorrhoids. As mentioned above, aloe has various medicinal effects, and depending on the purpose, it is used by taking or applying raw aloe, juice, juice, ointment, tablet, etc. By the way, when using aloe for the treatment of burns, cuts, and abrasions, which is expected to be most effective externally and has a large effect, the sooner the initial treatment, the better. Particularly in the case of treatment for burns, it is urgent, and therefore it is preferable to keep and use commercially available ointments. In addition to treating burns as quickly as possible, it is important to cool the affected area, and the degree of initial cooling determines the speed of recovery. In this respect, ointments have the disadvantage of not providing an initial cooling effect. Another treatment is to soak aloe grown at home in boiling water to sterilize it, then remove the outer skin and apply the jelly-like part of the leaf to the affected area. It has the advantage of being effective and allowing the medicinal components of aloe to be applied directly to the affected area, and is a well-known method of use, but it has the disadvantage of being cumbersome and time-consuming. The purpose of the present invention is to obtain an aloe preparation that has a large initial cooling effect without impairing the medicinal efficacy of aloe,
Its gist is that it is an external treatment material made by blending aloe or aloe extract with a hydrophilic hydrogel base and forming it into a sheet shape. Regarding the present invention, as the hydrophilic hydrogel base, those commonly used in the past are generally used. It may be synthetic or natural, and any of those conventionally used for hydrophilic gel bases can be used. Typical examples include saccharides and their derivatives, such as sodium alginate, gum arabic, dextrin, pullulan, amylose, gelatin, curdline, methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and carboxymethylcellulose, polyacrylic acid and its salts. (e.g., sodium salt, ammonium salt, alkanolamine salt, etc.), acrylic acid copolymers and their salts (e.g., acrylic acid/ethyl acrylate copolymer, potassium salt of acrylic acid/ethyl acrylate copolymer, etc.) , acrylic acid alkyl ester polymers (e.g., polyethyl acrylate, polyhydroxyethyl acrylate, polyethoxyethyl acrylate), maleic anhydride copolymers (e.g., methyl vinyl ether/maleic anhydride copolymer, isobutylene/anhydride) maleic acid copolymers, etc.) and their salts (e.g., sodium salts,
ammonium salts, etc.), polyvinyl alcohol and its derivatives (e.g., partially saponified polyvinyl alcohol, carboxylated polyvinyl alcohol, etc.), acrylamide polymers and their copolymers (e.g., acrylamide/acrylic acid copolymers, acrylamide/acrylonitrile,
(acrylic acid copolymer, acrylamide/acrylonitrile/acrylic acid ester copolymer, etc.),
Examples include polyvinylpyrrolidone. Such polymeric materials include cross-linking agents (e.g. polyisocyanates, polyepoxides, benzoyl peroxide, etc.)
It may be crosslinked using. The blending amount of the polymeric substance in the hydrophilic hydrogel base varies depending on the strength of the base and the setting of the cooling capacity, but is usually about 3 to 30% by weight.
If it is less than 3% by weight, the hydrogel strength will be insufficient even if it is used in a cross-linked state, and if it is more than 30% by weight, the viscosity during production will be too high and workability will be poor, and the solubility of the polymeric substance will be affected. Therefore, the amount of water that can be blended decreases, and the cooling ability tends to deteriorate. In addition, it is preferable to use polyhydric alcohols such as ethylene glycol, diethylene glycol, polyethylene glycol, propylene glycol, polypropylene glycol, and glycerin in combination in the base for the purpose of tackification and improving solubility during manufacturing. , usually 5 to 80% by weight.
If it is less than 5% by weight, no significant effect can be obtained by adding it, and if it is more than 80% by weight, the hydrogel strength and cooling ability will be poor. If the water content in the hydrophilic hydrogel base is 10% by weight or more, a cooling effect can be expected, but if it is less than 20% by weight, the cooling effect disappears quickly, and if it is 95% by weight or more,
Due to insufficient hydrogel strength, it is difficult to use depending on the shape and size. Therefore, the preferred water content is 25 to 70% by weight, more preferably 30 to 60% by weight, although it varies slightly depending on the polymer material used. Aloe or aloe extract is blended as a medicinal ingredient, but known bactericides, anti-inflammatory agents, preservatives, fillers, primary alcohols, etc. may be added depending on the purpose. As the aloe, it is preferable to use those listed in the pharmacopoeia (Cape aloe, Socotra aloe, and Aloe cylindrica), but of course other aloe species such as Natal aloe, Sambar aloe, Jafa aloe aloe, etc. can also be used. good. Aloe may be added in the form of its powder, aloe juice, or aloe extract. As the aloe extract, those prepared by extraction with water, alcohol such as ethanol, water-alcohol mixed solvent, etc. are used. Effects can be expected if the amount of aloe or aloe extract is 2% or more as aloe or aloe powder, and 0.8% or more as the above extract, but the extract content is preferably 1 to 15%. The therapeutic member of the present invention is manufactured by uniformly dispersing or dissolving aloe in a hydrophilic hydrogel base and spreading the same on a carrier. As the carrier, conventionally known materials such as cloth and plastic may be used. EXAMPLES The present invention will be described in more detail below with reference to Examples and Experimental Examples, but the present invention is not limited thereto. In the following description, "parts" means "parts by weight." Example 1 6 parts of sodium polyacrylate having an average degree of polymerization of 20,000 and 15 parts of glycerin are dissolved in 80 parts of water. Separately, 0.3 parts of triglycidyl isocyanurate is dissolved in 10 parts of water. Next, an aqueous solution of triglycidyl isocyanurate is added to the aqueous solution of sodium polyacrylate and glycerin while stirring, heated at about 70° C. for 1 hour and then cooled, and 50 parts of juice obtained by squeezing the herbal medicine of aloe are added and mixed. This mixture is applied to a rayon nonwoven fabric to a thickness of 1.0 mm to obtain a treatment member of the present invention. Example 2 90 parts of acrylic acid, 10 parts of butyl acrylate, 50 parts of polyoxypropylated sorbitol, and 2 parts of ammonium persulfate were dissolved in 350 parts of water, and polymerized at 60° C. for 8 hours in an inert gas stream. The resulting viscous liquid
60 parts of polyoxypropylated sorbitol to 100 parts,
After adding 30 parts of a 20% potassium hydroxide aqueous solution and 10 parts of a 10% triglycidyl isocyanurate aqueous solution and mixing them uniformly, 40 parts of an aqueous extract of pharmacopoeial aloe was added and mixed, and the mixture was spread on a 100μ thick rayon non-woven fabric. It is spread to a thickness of about 1 mm to obtain a sheet-like treatment member. Example 3 Maleic anhydride/methyl vinyl ether copolymer (maleic anhydride content 50% by weight) 20% aqueous solution
To 100 parts, 15 parts of diethylene glycol and 1 part of triethanolamine were added and mixed. After uniformly mixing, 20 parts of a 10% aqueous solution of glycerin diglycidyl ether and 50 parts of pharmacopoeial aloe powder were added to make a rayon nonwoven fabric with a thickness of 1.0 parts. mm and cross-linked at room temperature to obtain the treatment member of the present invention. Experimental Example 1 The preparations obtained in Examples 1 to 3 were applied to the burns shown in Table 1, the effectiveness was determined, and the results were
Shown in the table. As is clear from the above results, the treatment member of the present invention had a better therapeutic effect than commercially available aloe ointment.
【表】【table】
Claims (1)
キスを配合し、シート状に成型してなる外用治療
部材。 2 親水性含水ゲル基剤中の水含量が10〜95重量
%である特許請求の範囲第1項記載の外用治療部
材。 3 親水性含水ゲル基剤がポリアクリル酸および
その塩、アクリル酸共重合体およびその塩、無水
マレイン酸共重合体およびその塩、水溶性ポリア
ミド、ポロビニルアルコールおよびその誘導体な
らびに糖類およびその誘導体から選ばれる少なく
とも一種の親水性高分子物質よりなるものである
特許請求の範囲第1項記載の外用治療部材。 4 親水性含水ゲル基剤が3〜30重量%の親水性
高分子物質を含有するものである特許請求の範囲
第1又は2項記載の外用治療部材。[Scope of Claims] 1. An external treatment member prepared by blending aloe or aloe extract with a hydrophilic hydrogel base and molding it into a sheet. 2. The external treatment member according to claim 1, wherein the water content in the hydrophilic hydrogel base is 10 to 95% by weight. 3. The hydrophilic hydrogel base is made of polyacrylic acid and its salts, acrylic acid copolymers and their salts, maleic anhydride copolymers and their salts, water-soluble polyamides, polovinyl alcohols and their derivatives, and saccharides and their derivatives. The external treatment member according to claim 1, which is made of at least one selected hydrophilic polymer substance. 4. The external treatment member according to claim 1 or 2, wherein the hydrophilic hydrogel base contains 3 to 30% by weight of a hydrophilic polymeric substance.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58075932A JPS59204117A (en) | 1983-04-28 | 1983-04-28 | Therapeutic material for external application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58075932A JPS59204117A (en) | 1983-04-28 | 1983-04-28 | Therapeutic material for external application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59204117A JPS59204117A (en) | 1984-11-19 |
| JPH0331172B2 true JPH0331172B2 (en) | 1991-05-02 |
Family
ID=13590525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58075932A Granted JPS59204117A (en) | 1983-04-28 | 1983-04-28 | Therapeutic material for external application |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59204117A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63310818A (en) * | 1987-06-12 | 1988-12-19 | Sato Seiyaku Kk | Sheet preparation to be applied to oral mucosa |
| JPH08291057A (en) * | 1995-02-22 | 1996-11-05 | Yuutoku Yakuhin Kogyo Kk | Cataplasm |
| KR20020008886A (en) * | 2000-07-20 | 2002-02-01 | 이상영 | Burn dermatitis from natural materials and preparation method thereof |
| JP2007320886A (en) * | 2006-05-31 | 2007-12-13 | Isp Japan Kk | Water-containing gel sheet and method for producing the same |
-
1983
- 1983-04-28 JP JP58075932A patent/JPS59204117A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59204117A (en) | 1984-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69120107T2 (en) | Basis or auxiliary material for external use as well as compositions containing this or these for external use on a human being or animal | |
| KR100349020B1 (en) | Gels Formed by the Interaction of Polyvinylpyrrolidone with Chitosan Derivatives | |
| KR100593717B1 (en) | Aqueous adhesive solids | |
| JP2007512410A (en) | Skin adhesive hydrogel | |
| JPH02202814A (en) | Plaster preparation for mucosa of oral cavity | |
| HUP0201621A2 (en) | Adhesive material, process for producing them, tape, fotter note and transdermal tape | |
| JP2010013474A (en) | Topical patch preparation containing delayed-type hypersensitivity inducer and method for using the same | |
| JP4596751B2 (en) | Anti-inflammatory analgesic patch | |
| JP3908275B2 (en) | Cold seat | |
| JP2002020274A (en) | Non-steroidal anti-inflammatory analgesic external patch and external patch | |
| US20060079640A1 (en) | Adhesive composition for dermal patch and production process thereof | |
| JP3064417B2 (en) | Controlled release formulations and methods | |
| JP4575632B2 (en) | Drugs for migraine relief | |
| CN112689505B (en) | Water-containing patch | |
| JPH08243377A (en) | Alcohol-containing gel body | |
| JPH0331172B2 (en) | ||
| JPWO2001043736A1 (en) | Migraine relief medications | |
| JP2001151973A (en) | Alkaline hydrous gel | |
| JP3145857B2 (en) | Aqueous warming patch | |
| JPH11180887A (en) | Anti-inflammatory analgesic patch | |
| JP2003212760A (en) | Gel composition, gel sheet | |
| JPS6034923B2 (en) | Sponge-like medical band | |
| JPS60260513A (en) | Poultice | |
| JPH0336806B2 (en) | ||
| JP3507238B2 (en) | Water-soluble cataplasm composition |